| DOI | Resolve DOI: https://doi.org/10.1016/S1359-6349(08)72049-4 |
|---|
| Author | Search for: Gabathuler, R.; Search for: Demeule, M.; Search for: Regina, A.; Search for: Che, C.; Search for: Thomas, F.; Search for: Abulrob, A.1; Search for: Smith, Q.R.; Search for: Stanimirovic, D.1; Search for: Beliveau, R.; Search for: Castaigne, J.P. |
|---|
| Affiliation | - National Research Council of Canada
|
|---|
| Format | Text, Article |
|---|
| Conference | 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Oct. 22, 2008 |
|---|
| Subject | blood-brain barrier; Paclitaxel; ANG1005; glioblastoma; drug delivery technology |
|---|
| Abstract | In situ brain perfusion were used to assess the brain uptake of our conjugates. Analysis of tissues was done after extraction by LC-MS-MS or HPLC. Xenograft models of glioblastoma (U87) were established by intercranial stereotaxic injections of U87 cells in mice and rats. |
|---|
| Publication date | 2008-10 |
|---|
| In | |
|---|
| Language | English |
|---|
| Peer reviewed | Yes |
|---|
| NPARC number | 21275174 |
|---|
| Export citation | Export as RIS |
|---|
| Report a correction | Report a correction (opens in a new tab) |
|---|
| Record identifier | 2d20c5a7-cacb-4b13-87da-c16773a45e99 |
|---|
| Record created | 2015-05-22 |
|---|
| Record modified | 2020-04-15 |
|---|
